What is ETFMG Treatments, Testing and Advancements ETF (GERM)?

ETFMG Treatments, Testing and Advancements ETF (GERM) is an ETF in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

What is the current price of GERM?

The current price of GERM is $19.16. Prices are updated in real time on Stocks360.

What is GERM's market capitalization?

GERM's market capitalization is $9,586,475.00, placing it in the small-cap tier.

ETFMG Treatments, Testing and Advancements ETF (GERM)

ETF analysis · AMEX · Financial Services · Asset Management

$19.16

Market Cap

$9.59M

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.02

Day Range

$19.16 – $19.28

52-wk Range

$16.32 – $20.20

Avg Volume

N/A

Volume

4.83K

ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund in the Financial Services sector. Latest price: $19.16. Market cap $9.59M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About ETFMG Treatments, Testing and Advancements ETF

This fund aims to replicate the investment performance of U.S.-listed companies, including equity shares and depositary receipts, that are primarily engaged in two sectors: either researching, developing, and bringing to market treatments or vaccines for infectious diseases, or producing, researching, and supplying biological diagnostic tests for patients. At least 80% of the fund's total assets will be invested in the specific securities that constitute its underlying index. It is important to note that this fund is structured as non-diversified.